BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8306090)

  • 1. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
    Fan F; Compton DR; Ward S; Melvin L; Martin BR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1383-90. PubMed ID: 7996450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia.
    Pertwee R; Griffin G; Hanus L; Mechoulam R
    Eur J Pharmacol; 1994 Jul; 259(2):115-20. PubMed ID: 7957604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AM630, a competitive cannabinoid receptor antagonist.
    Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
    Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
    De Vry J; Jentzsch KR; Kuhl E; Eckel G
    Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
    Bloom AS; Edgemond WS; Moldvan JC
    Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR
    Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
    Welch SP
    Drug Alcohol Depend; 1997 Apr; 45(1-2):39-45. PubMed ID: 9179505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
    Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
    Raffa RB; Stone DJ; Hipp SJ
    Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
    Bueb JL; Lambert DM; Tschirhart EJ
    Biochim Biophys Acta; 2001 Apr; 1538(2-3):252-9. PubMed ID: 11336796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH; Oriowo MA
    Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of anandamide in rats.
    Wiley J; Balster R; Martin B
    Eur J Pharmacol; 1995 Mar; 276(1-2):49-54. PubMed ID: 7781695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.